A chimeric growth factor receptor (CSF1R/IR) was constructed by splicing cDNA sequences encoding the extracellular ligand binding domain of the human colony stimulating factor-1 (CSF-1) receptor to sequences encoding the transmembrane and cytoplasmic domains of the human insulin receptor. The addition of CSF-1 to cells transfected with the CSF1R/IR chimera cDNA stimulated the tyrosine phosphorylation of a protein that was immunoprecipitated by an antibody directed against the carboxyl terminus of the insulin receptor. Phosphopeptide maps of the 32 P-labeled CSF1R/IR protein revealed the same pattern of phosphorylation observed in 32 P-labeled insulin receptor  subunits. CSF-1 stimulated the tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1) and Shc in cells expressing the CSF1R/IR chimera. Lipid accumulation and the expression of a differentiation-specific marker demonstrated that 3T3-L1 preadipocytes undergo CSF-1-dependent differentiation when transfected with the CSF1R/IR chimera cDNA but not when transfected with the expression vector alone. A 12-amino acid deletion within the juxtamembrane region of the CSF1R/IR (CSF1R/IR⌬960) blocked CSF-1-stimulated phosphorylation of IRS-1 and Shc but did not inhibit CSF-1-mediated differentiation of 3T3-L1 preadipocytes. These observations indicate that adipocyte differentiation can be initiated by intracellular pathways that do not require tyrosine phosphorylation of IRS-1 or Shc.A primary goal in the study of insulin action is the identification of the intracellular pathways that lead ultimately to changes in the rates of growth, development, and metabolism in primary target tissues of insulin (e.g. adipose, muscle, and liver). One strategy for the study of insulin-sensitive intracellular signaling has been to identify structural features within the insulin receptor that are important components of divergent signal transduction pathways. The goal of this strategy has been to create mutations within specific receptor sequences that result in the selective disruption of some insulin-regulated metabolic pathways while leaving others intact. Deletion mutagenesis of the insulin receptor cytoplasmic domain has generated insulin receptors with altered biological properties (1-4). Experiments with these receptor mutants have led to the suggestion that different regions of the insulin receptor cytoplasmic domain may play roles in modulating the distinct biological effects of insulin. Most mutations of the insulin receptor cytoplasmic domain have removed or altered autophosphorylation sites within the cytoplasmic domain (5-8). This approach has furthered the notion that tyrosine phosphorylation and the tyrosine kinase encoded within the receptor  subunit are essential components of normal insulin action. The majority of structure/function analyses of the insulin receptor, however, have been performed in cells expressing low levels of endogenous insulin receptors, e.g. Chinese hamster ovary (CHO) 1 or Rat-1 fibroblasts cell lines (reviewed in Ref. 9). Although su...